BRUKER CORP (BRKR) Stock Fundamental Analysis
NASDAQ:BRKR - Nasdaq - US1167941087 - Common Stock - Currency: USD
BRKR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. BRKR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
In the past year BRKR had a positive cash flow from operations.
BRKR had positive earnings in each of the past 5 years.
In the past 5 years BRKR always reported a positive cash flow from operatings.
1.2 Ratios
BRKR's Return On Assets of 1.34% is fine compared to the rest of the industry. BRKR outperforms 70.91% of its industry peers.
BRKR has a Return On Equity of 4.38%. This is in the better half of the industry: BRKR outperforms 74.55% of its industry peers.
BRKR's Return On Invested Capital of 5.54% is fine compared to the rest of the industry. BRKR outperforms 69.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is below the industry average of 13.60%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.38% | ||
| ROIC | 5.54% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKR's Profit Margin of 2.31% is fine compared to the rest of the industry. BRKR outperforms 70.91% of its industry peers.
BRKR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 10.99%, BRKR is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
In the last couple of years the Operating Margin of BRKR has declined.
Looking at the Gross Margin, with a value of 49.28%, BRKR is in line with its industry, outperforming 50.91% of the companies in the same industry.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.99% | ||
| PM (TTM) | 2.31% | ||
| GM | 49.28% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRKR is creating some value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
Compared to 5 years ago, BRKR has less shares outstanding
BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.36 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score of 2.36. This is comparable to the rest of the industry: BRKR outperforms 58.18% of its industry peers.
The Debt to FCF ratio of BRKR is 12.11, which is on the high side as it means it would take BRKR, 12.11 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.11, BRKR is in line with its industry, outperforming 54.55% of the companies in the same industry.
A Debt/Equity ratio of 1.14 is on the high side and indicates that BRKR has dependencies on debt financing.
With a Debt to Equity ratio value of 1.14, BRKR is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 12.11 | ||
| Altman-Z | 2.36 |
ROIC/WACC0.6
WACC9.18%
2.3 Liquidity
A Current Ratio of 1.57 indicates that BRKR should not have too much problems paying its short term obligations.
The Current ratio of BRKR (1.57) is worse than 70.91% of its industry peers.
A Quick Ratio of 0.72 indicates that BRKR may have some problems paying its short term obligations.
BRKR has a worse Quick ratio (0.72) than 89.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
BRKR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.56%.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
BRKR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.84%.
Measured over the past years, BRKR shows a quite strong growth in Revenue. The Revenue has been growing by 10.19% on average per year.
EPS 1Y (TTM)-8.56%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-11.32%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%11.04%
3.2 Future
Based on estimates for the next years, BRKR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.88% on average per year.
The Revenue is expected to grow by 5.08% on average over the next years.
EPS Next Y4.28%
EPS Next 2Y8.46%
EPS Next 3Y11.25%
EPS Next 5Y10.88%
Revenue Next Year4.74%
Revenue Next 2Y4.46%
Revenue Next 3Y4.87%
Revenue Next 5Y5.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.29, the valuation of BRKR can be described as correct.
Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 87.27% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.32, BRKR is valued a bit cheaper.
BRKR is valuated correctly with a Price/Forward Earnings ratio of 13.50.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaper than 89.09% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRKR to the average of the S&P500 Index (22.13), we can say BRKR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.29 | ||
| Fwd PE | 13.5 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRKR is valued cheaper than 87.27% of the companies in the same industry.
BRKR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BRKR is cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.23 | ||
| EV/EBITDA | 13.37 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRKR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.8
PEG (5Y)1.82
EPS Next 2Y8.46%
EPS Next 3Y11.25%
5. Dividend
5.1 Amount
With a yearly dividend of 0.50%, BRKR is not a good candidate for dividend investing.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.51. BRKR pays more dividend than 90.91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has paid a dividend for at least 10 years, which is a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
BRKR pays out 38.44% of its income as dividend. This is a sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.44%
EPS Next 2Y8.46%
EPS Next 3Y11.25%
NASDAQ:BRKR (6/16/2025, 10:00:06 AM)
38.285
-0.02 (-0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.12%
Inst Owner Change0.11%
Ins Owners26.98%
Ins Owner Change0.13%
Market Cap5.80B
Analysts75.45
Price Target54.27 (41.75%)
Short Float %7.49%
Short Ratio3.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.44%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.87%
Min EPS beat(2)1.16%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)6.57%
EPS beat(8)6
Avg EPS beat(8)5.91%
EPS beat(12)9
Avg EPS beat(12)6.53%
EPS beat(16)12
Avg EPS beat(16)9.18%
Revenue beat(2)1
Avg Revenue beat(2)1.07%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.17%
Min Revenue beat(4)-1.45%
Max Revenue beat(4)2.76%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)1.07%
Revenue beat(16)11
Avg Revenue beat(16)1.46%
PT rev (1m)-8.95%
PT rev (3m)-20.17%
EPS NQ rev (1m)-1.13%
EPS NQ rev (3m)-22.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.51%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-2.25%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.29 | ||
| Fwd PE | 13.5 | ||
| P/S | 1.68 | ||
| P/FCF | 33.23 | ||
| P/OCF | 19.7 | ||
| P/B | 3.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.37 |
EPS(TTM)2.35
EY6.14%
EPS(NY)2.84
Fwd EY7.41%
FCF(TTM)1.15
FCFY3.01%
OCF(TTM)1.94
OCFY5.08%
SpS22.74
BVpS11.99
TBVpS-4.07
PEG (NY)3.8
PEG (5Y)1.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 4.38% | ||
| ROCE | 8.25% | ||
| ROIC | 5.54% | ||
| ROICexc | 5.77% | ||
| ROICexgc | 12.9% | ||
| OM | 10.99% | ||
| PM (TTM) | 2.31% | ||
| GM | 49.28% | ||
| FCFM | 5.07% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score3
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 12.11 | ||
| Debt/EBITDA | 3.59 | ||
| Cap/Depr | 60.1% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 50.93% | ||
| Profit Quality | 219.35% | ||
| Current Ratio | 1.57 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 2.36 |
F-Score3
WACC9.18%
ROIC/WACC0.6
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.56%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-11.32%
EPS Next Y4.28%
EPS Next 2Y8.46%
EPS Next 3Y11.25%
EPS Next 5Y10.88%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%11.04%
Revenue Next Year4.74%
Revenue Next 2Y4.46%
Revenue Next 3Y4.87%
Revenue Next 5Y5.08%
EBIT growth 1Y-13.58%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year29.66%
EBIT Next 3Y16.46%
EBIT Next 5Y14.77%
FCF growth 1Y17.26%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y3.66%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%